NASDAQ:TRIL
Delisted
Trillium Therapeutics Inc. Stock News
$18.44
+0 (+0%)
At Close: May 27, 2022
Trillium Therapeutics Announces Formation of Scientific Advisory Board
04:15pm, Monday, 02'nd Nov 2020
CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative
